Active surveillance for stage I testis cancer: two steps forward one step back.
Raghavan
D
D
Rosewell Park Cancer Institute, Division of Solid Tumor Oncology, Buffalo, NY 14263.
D002985:Clinical Protocols; D003362:Cost-Benefit Analysis; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000628:therapy*; D013736:Testicular Neoplasms / Q000628:therapy*